| Literature DB >> 28821766 |
Zhong-Jian Guo1, Meng-Han Yu2, Xian-Yun Dong2, Wei-Li Wang3, Ting Tian2, Xian-Yin Yu2, Xu-Dong Tang4.
Abstract
Polyhedra can encapsulate other proteins and have potential applications as protein stabilizers. The extremely stable polyhedra matrix may provide a platform for future engineered micro-crystal devices. However, the protein composition of the polyhedra matrix remains largely unknown. In this study, the occlusion-derived virus (ODV)-removed BmNPV polyhedra matrix fraction was subjected to SDS-PAGE and then an LC-ESI-MS/MS analysis using a Thermo Scientific Q Exactive mass spectrometer. In total, 28 host and 91 viral proteins were identified. The host components were grouped into one of six categories, i.e., chaperones, ubiquitin and related proteins, host helicases, cytoskeleton-related proteins, RNA-binding proteins and others, according to their predicted Pfam domain(s). Most viral proteins may not be essential for polyhedra assembly, as evidenced by studies in the literature showing that polyhedra formation occurs in the nucleus upon the disruption of individual genes. The structural role of these proteins in baculovirus replication will be of significant interest in future studies. The immobilization of enhanced green fluorescent protein (eGFP) into the polyhedra by fusing with the C-terminus of BM134 that is encoded by open reading frame (ORF) 134 suggested that the polyhedra had a powerful capacity to trap foreign proteins, and BM134 was a potential carrier for incorporating proteins of interest into the polyhedra.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28821766 PMCID: PMC5562830 DOI: 10.1038/s41598-017-08987-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1BmNPV polyhedra matrix proteins were separated on 12% (A) and 15% (B) SDS-PAGE gels. Purified polyhedra were treated with an alkaline solution. Undissolved polyhedra were removed by low-speed centrifugation at 500 × g. The resulting supernatant was collected and then centrifuged by continuous sucrose gradients to remove the ODVs. Protein sample over the upper gradient was separated by SDS-PAGE. Proteins on the gel were excised into five contiguous sections (M1 to M5) and subjected to in-gel digestion and LC-ESI-MS/MS analysis. Two M5 sections shown in (A) and (B) were combined for the determination. Lane M, protein marker.
Host proteins identified in the BmNPV polyhedral matrix using the LC-ESI-MS/MS Q Exactive technique.
| Classification | Protein | Pfam domain(s) | Abbreviation | Size (amino acids) | Gel region(s) (No. of peptides identified; Coverage (%)) |
|---|---|---|---|---|---|
| Chaperones | BGIBMGA002381-PA | 70 kilodalton heat shock cognate/protein | HSP70-4 | 649 | M1 (5; 10.63), M2 (16; 34.98), M3 (8; 18.03) |
| BGIBMGA006196-PA | 40 kilodalton heat shock protein | HSP40 | 313 | M3 (3; 13.74) | |
| BGIBMGA002429-PA | Cyclophilin type peptidyl-prolyl cis-trans isomerase/cyclophilin-like domain | Cyclophilin A | 165 | M5 (6; 58.18) | |
| BGIBMGA004331-PA | FK506 binding protein | FKBP | 108 | M5 (2; 32.41) | |
| Ubiquitin and related proteins | BGIBMGA011805-PA | Ubiquitin carboxyl-terminal hydrolase | UCH | 665 | M1 (1; 4.36), M2 (1; 2.56) |
| BGIBMGA011581-PA | Small ubiquitin-related modifier | SUMO | 91 | M1 (1; 13.19), M2 (1; 13.19), M3 (1; 13.19) | |
| BGIBMGA001549-PA | Ubiquitin | Ubiquitin | 153 | M3 (3; 26.80), M5 (3; 26.80) | |
| Helicases | BGIBMGA011746-PA | DEAD/DEAH box helicase | DEAD/H | 569 | M1 (3; 7.56), M2 (6; 16.52), M3 (11; 26.89) |
| BGIBMGA011965-PA | DEAD/DEAH box helicase | DEAD/H | 628 | M2 (5; 13.69), M3 (8; 20.70) | |
| BGIBMGA010673-PA | DEAD/DEAH box helicase | DEAD/H | 372 | M3 (9; 33.60) | |
| BGIBMGA004822-PA | DEAD/DEAH box helicase | DEAD/H | 405 | M3 (4; 15.31) | |
| Cytoskeleton- related proteins | BGIBMGA005576-PA | Actin | Actin | 344 | M1 (4; 23.84) |
| BGIBMGA002981-PA | Profilin | Profilin | 126 | M5 (3; 47.62) | |
| BGIBMGA007092-PA | Calponin homology domain, calponin family repeat | CH | 173 | M5 (6; 54.91) | |
| RNA binding proteins | BGIBMGA006405-PA | RNA recognition motif | RRM | 361 | M3 (5; 15.80) |
| BGIBMGA014155-PA | K Homology domain | KH | 377 | M3 (6; 27.98) | |
| BGIBMGA004881-PA | RNA recognition motif | RRM | 252 | M3 (4; 23.02), M5 (3; 17.86) | |
| BGIBMGA013464-PA | RNA recognition motif | RRM | 287 | M3 (3; 15.33) | |
| BGIBMGA007410-PA | RNA recognition motif | RRM | 314 | M3 (3; 15.61) | |
| BGIBMGA013100-PA | Like Sm protein | LSm | 130 | M5 (2; 23.85) | |
| Others | BGIBMGA003126-PA | Nup93/Nic96 | NIC | 820 | M1 (3; 5.24), |
| BGIBMGA000808-PA | XRN 5’-3′ exonuclease | XRN_N | 322 | M1 (2; 8.39), | |
| BGIBMGA005650-PA | CAF1 family ribonuclease | 479 | M1 (3; 8.77), M2 (3; 8.77), | ||
| BGIBMGA008447-PA | Nuclear transport factor 2 domain, Nuclear RNA export factor 1 | NTF2 NXF1 | 613 | M2 (2; 4.89), | |
| BGIBMGA001106-PA | Ribosomal protein L21e | 159 | M5 (3; 24.53) | ||
| BGIBMGA006867-PA | Ribosomal protein S8 | 129 | M5 (2; 23.26) | ||
| BGIBMGA011282-PA | Ribosomal S13/S15 N-terminal domain | 151 | M5 (2; 19.21) | ||
| BGIBMGA009106-PA | glutathione S-transferase 2 | GST-2 | 416 | M5 (4; 13.22) |
Figure 2Host protein HSP70-4 was associated with the BmNPV polyhedra matrix. (A) Western blot analysis of HSP70-4 in the BmNPV polyhedra matrix. The fraction over the upper sucrose gradient was loaded for the Western blot analysis. Images were visualized using a chemiluminescence detection system. Lane M, the protein marker. (B) Co-localization of polyhedrin with HSP70-4 in the polyhedra in infected BmN cells. Cells were infected with the BmNPV T3 isolate at an MOI of 10 TCID50/cell. At 48 h p.i. the cells were fixed, permeabilized, and then incubated in a buffer containing mouse monoclonal anti-polyhedrin and rabbit polyclonal anti-HSC/HSP70 antibodies. Next, the cells were stained with the Texas Red-conjugated goat anti-mouse IgG, FITC-conjugated goat anti-rabbit IgG and Hoechst 33342, washed with 1× PBS, and then imaged under a Leica TCS SP5 confocal laser scanning microscope using the Texas Red filter set for the Texas Red-conjugated antibody and the FITC filter set for the FITC-conjugated antibody. In the merged images, yellow suggested an association between polyhedrin and HSP70-4 in the polyhedra matrix (Merge I), and magenta indicated the nuclear location of the polyhedra (Merge II).
Viral proteins identified in the BmNPV polyhedral matrix by a Q Exactive LC-ESI-MS/MS analysis.
| BmNPV ORF | AcMNPV ORF | Protein designation | Predicted molecular mass (kDa) | Location in ODV virion† | Location in BV virion† | OB formation when deleted? (ODV embedded?) | Gel region(s) (No. of peptides identified; Coverage (%)) |
|---|---|---|---|---|---|---|---|
| 1 | 8 | Polyhedrin | 28.8 | ENC[ | NC[ | No | M1 (18; 64.9), M2 (28; 97.55), M3 (27; 97.55), M4 (25; 97.55), M5 (23; 96.33) |
| 2 | 9 | P78/83 | 60.9 | NC[ | NC[ | M2(6; 16.42), M3 (3; 9.23), M5 (1; 2.40) | |
| 3 | 10 | PK1 | 32.4 | NC[ | NC[ | No[ | M3 (1; 4.36) |
| 4 | 11 | 39.8 | Yes(No)[ | M1 (1; 4.12), M3 (9; 36.47) | |||
| 5 | 13 | 39.3 | Yes(Yes)[ | M4 (1; 2.42) | |||
| 7 | 15 | EGT | 57.0 | Yes(Yes)[ | M5 (1; 2.77) | ||
| 8 | 16 | BV/ODV-E26 | 26.2 | ENC[ | ENC[ | Yes(Yes)[ | M5 (1; 6.11) |
| 9 | 17 | 24.1 | ENC[ | Yes(Yes)[ | M5(2; 14.29) | ||
| 10 | 18 | 41.5 | Yes(Yes)[ | M1 (1; 5.06), M3 (6; 24.44) | |||
| 11 | 19 | 12.5 | M2 (1; 15.45) | ||||
| 14 | 23 | F protein | 78.0 | E[ | E[ | Yes(Yes)[ | M1 (1; 2.23) |
| 15 | 24 | PKIP | 19.4 | ENC[ | No[ | M5 (7; 49.70) | |
| 17 | 26 | 14.5 | Unknown[ | M1 (1; 9.30), M5 (7; 25.58) | |||
| 19 | 28 | LEF-6 | 20.3 | Unkown[ | M5 (1; 6.36) | ||
| 22a | M3 (1; 20.37) | ||||||
| 23 | 31 | SOD | 16.3 | E[ | Yes(Yes)[ | M1 (2; 19.87), M3 (2; 15.23), M5(5; 53.64) | |
| 26 | 35 | Ubiquitin | 8.7 | E[ | E[ | Yes[ | M1 (2; 32.47), M2 (1; 20.78), M3 (3; 49.35), M5(2; 44.16) |
| 27 | 36 | PP31 | 31.5 | Unknown[ | Yes(Yes)[ | M1 (1; 5.78), M2 (1; 5.42) | |
| 29 | 38 | 25.5 | E[ | M1 (1; 3.69), M3 (1; 4.15), M5 (1; 5.07) | |||
| 30 | 39 | P43 | 43.3 | Yes[ | M2 (1; 4.14), M3 (1; 4.14) | ||
| 34 | 43 | 9.0 | Yes, but few[ | M3 (1; 19.23), M5(6; 61.54) | |||
| 36 | 45 | 22.5 | M3 (1; 5.18) | ||||
| 37 | 46 | ODV-E66 | 79.2 | E[ | Yes(Yes)[ | M1(10; 21.08), M2(21; 49.29), M3(17; 41.60), M5(5; 13.25) | |
| 38 | 47 | ETS/TRAX | 10.5 | M5 (1; 12.36) | |||
| 40 | 51 | 37.8 | ENC[ | Unknown[ | M3 (3; 13.48) | ||
| 43 | 54 | VP1054 | 42.0 | NC[ | NC[ | Yes(No)[ | M3 (2; 7.12) |
| 47 | 58/59 | ChaB | 37.8 | NC[ | NC[ | M5(4; 46.2) | |
| 48 | 60 | 9.7 | M1 (1; 12.05), M3 (1; 12.05), M5(2; 13.25) | ||||
| 49 | 61 | FP25K | 25.3 | NC[ | NC[ | Yes, but few(Yes, but few)[ | M5 (1; 8.88) |
| 51 | 63 | 18.5 | E[ | M4 (1; 5.81) | |||
| 53 | 65 | DNAPOL | 114.4 | Unknown[ | No[ | M1 (1; 2.64) | |
| 54 | 66 | 93.3 | ENC[ | NC[ | Yes[ | M1(8; 15.16), M2(2; 3.85) | |
| 55 | 67 | LEF-3 | 44.9 | Unknown[ | M2(1; 3.90), M3(6; 20.26), M4(1; 3.38), M5 (1; 2.60) | ||
| 57 | 69 | 30.4 | Yes(Yes)[ | M5 (1; 7.63) | |||
| 59 | 73 | 11.5 | Unknown[ | Yes(Yes)[ | M5(4; 58.59) | ||
| 60 | 74 | 31.0 | Unknown[ | E[ | M3 (1; 3.36) | ||
| 61 | 75 | 15.5 | E[ | ENC[ | M5 (5; 35.34) | ||
| 62 | 76 | 9.6 | E[ | E[ | Yes(No)[ | M1 (1; 15.29), M5(2; 16.47) | |
| 63 | 77 | VLF-1 | 44.3 | ENC[ | NC[ | Yes, but few (No)[ | M1 (6; 17.41), M2 (3; 9.50), M3 (8; 26.65), M5(4; 12.93) |
| 65 | 79 | 12.2 | Unknown[ | Yes(Yes)[ | M5 (2; 17.31) | ||
| 66 | 80 | GP41 | 44.9 | ENC[ | ENC[ | Yes[ | M1 (12; 41.69), M2 (6; 17.12), M3 (15; 59.31), M4(1; 6.20), M5(2; 9.18) |
| 67 | 81 | 27.0 | Unknown[ | Yes(No)[ | M2 (1; 4.27), M5 (1; 5.56) | ||
| 68 | 82 | TLP | 20.1 | E[ | Yes(Yes)[ | M2 (2; 25.41), M4(1; 4.42) | |
| 69 | 83 | 95.8 | E[ | Yes(No)[ | M1 (2; 4.53), M2 (2; 4.77), M5 (1; 2.26) | ||
| 70 | 87 | VP15 | 15.1 | M1 (1; 17.46), M2 (1; 17.46), M3 (1; 17.46) | |||
| 71 | 88 | CG30 | 30.7 | Unknown[ | Yes(Yes)[ | M1 (1; 5.24), M3 (1; 6.37) | |
| 72 | 89 | VP39 | 39.3 | NC[ | NC[ | M1 (1; 4.00), M3 (4; 20.29), M5 (1; 4.00) | |
| 75 | 92 | P33 | 30.9 | ENC[ | ENC[ | Yes(No and singly enveloped nucleocapsid)[ | M1(7; 22.01), M2(7; 32.05), M3(8; 28.96), M4(16; 77.22), M5(14; 62.93) |
| 76 | 93 | NC[ | ENC[ | Yes(No)[ | M5(4; 32.92) | ||
| 77 | 94 | ODV-E25 | 25.6 | E[ | E[ | Yes(No)[ | M1 (2; 15.35), M2 (1; 7.89), M3 (3; 28.07), M5(10; 60.96) |
| 78 | 95 | DNA helicase/P143 | 143.6 | Unknown[ | M2 (1; 0.65), M5 (1; 1.15) | ||
| 79 | 96 | PIF-4 | 21.0 | E[ | E[ | Yes[ | M5 (1; 8.79) |
| 80 | BRO-b | 27.5 | M2 (1; 4.18) | ||||
| 81 | BRO-c | 35.9 | M4(1; 2.83), M5 (2; 7.55) | ||||
| 82 | 98 | 38 K | 38.0 | NC[ | NC[ | Yes(No)[ | M3 (3; 11.88) |
| 84 | 100 | P6.9 | 8.1 | NC[ | NC[ | Yes(No)[ | M1 (1; 12.31) |
| 85 | 101 | BV/ODV-C42 | 41.6 | NC[ | NC[ | M3 (5; 21.55), M5 (1; 1.93) | |
| 87 | 103 | P48 | 45.4 | ENC[ | Yes(No)[ | M1 (5; 12.66), M2 (3; 10.34), M3 (12; 39.02), M5 (2; 5.17) | |
| 88 | 104 | VP80 | 79.9 | ENC[ | NC[ | M1 (9; 19.65), M2 (10; 23.12), M3 (7; 15.75) | |
| 91 | 108 | 11.8 | E[ | Yes(Yes)[ | M3 (1; 27.62) | ||
| 92 | 109 | ODV-EC43 | 45.0 | ENC[ | ENC[ | Yes(No)[ | M1 (5; 18.41), M3 (14; 53.96), M5(4; 12.79) |
| 92a | 6.8 | M2 (1; 47.46) | |||||
| 93 | 111 | 8.2 | M1 (1; 20.09), M5 (1; 14.93) | ||||
| 94 | 114 | 49.4 | Unknown[ | Unknown[ | Yes(Yes)[ | M1 (3; 10.14), M3 (11; 39.86), M5(3; 12.74) | |
| 95 | 115 | PIF-3 | 23.0 | E[ | Yes(Yes)[ | ||
| 95a | 116 | M1 (1; 25.00) | |||||
| 98 | 120 | 9.5 | M5 (1; 13.41) | ||||
| 100 | 123 | PK2 | 26.0 | M5 (6; 28.89) | |||
| 104 | 127 | V-cath | 36.9 | ENC[ | M1 (1; 3.10), M5 (4; 17.96) | ||
| 106 | 129 | P24 | 21.8 | NC[ | NC[ | M1 (6; 37.44), M2 (5; 46.15), M3 (8; 58.97), M4 (2; 11.28), M5 (15; 73.33) | |
| 107 | 130 | GP16 | 12.1 | Yes(Yes)[ | M5 (1; 10.38) | ||
| 108 | 131 | PEP | 35.4 | NC[ | NC[ | Yes(Yes)[ | M1 (5; 16.51), M2 (2; 9.52), M3 (7; 32.70), M4 (3; 19.68), M5(5; 26.03) |
| 109 | 132 | 25.2 | NC[ | NC[ | Yes(Few)[ | M4 (1; 4.09) | |
| 110 | 133 | ALK-EXO | 48.5 | Unknown[ | M3 (1; 1.67) | ||
| 110a | M3 (1; 28.07) | ||||||
| 111 | Yes(Yes)[ | M3 (1; 20.00) | |||||
| 112 | 135 | P35 | 34.5 | Yes(Yes)[ | M3 (6; 24.08), M5(2; 11.04) | ||
| 114 | 137 | P10 | 7.5 | Yes(Yes)[ | M5 (1; 27.14) | ||
| 115 | 138 | P74/PIF-0 | 74.0 | E[ | Yes(Yes)[ | M5 (1; 1.71) | |
| 116 | 139 | ME53 | 52.6 | NC[ | NC[ | Yes[ | M1 (1; 2.00), M3 (6; 19.73), M5 (1; 2.00) |
| 117 | 141 | EXON0 | 30.1 | Unknown[ | NC[ | Yes[ | M3 (1; 4.21), M5 (1; 5.36) |
| 118 | 142 | 55.5 | ENC[ | NC[ | Yes(No)[ | M1 (8; 21.22), M2 (15; 47.90), M3 (16; 41.06), M5(2; 4.2) | |
| 119 | 143 | ODV-E18 | 10.4 | E[ | E[ | Yes[ | M5 (1; 23.76) |
| 120 | 144 | ODV-EC27 | 33.5 | ENC[ | NC[ | M3 (7; 31.03) | |
| 121 | 145 | 11.0 | Unknown[ | Unknown[ | Yes(Yes)[ | M5 (1; 22.11) | |
| 122 | 146 | 22.9 | Unknown[ | NC[ | Yes[ | M5(4; 28.36) | |
| 124 | 148 | ODV-E56/PIF-5 | 41.3 | E[ | Unknown[ | Yes(Yes)[ | M1 (1; 5.33), M3 (5; 24.00), M5(3; 9.6) |
| 125 | 149 | 12.3 | M5 (1; 27.36) | ||||
| 128 | 153 | PE38 | 36.1 | Yes(Yes)[ | M5 (1; 3.24) | ||
| 129 | 154 | 8.9 | M3 (3; 66.23), M5 (3; 67.53) | ||||
| 130 | 1 | PTP | 19.3 | Unknown[ | ENC[ | Yes(Yes)[ | M5 (1; 9.52) |
| 131 | 2 | BRO-d | 40.1 | M2 (2; 5.73) | |||
| 134 | 5 | 12.4 | Unknown[ | M1(3; 40.37), M2(2; 32.11), M3(2; 32.11), M4(3; 40.37), M5(10; 72.38) |
†Proteins were reported to be envelope (E)-, envelope-and-nucleocapsid (ENC)-, and/or nucleocapsid (NC)-associated components of BV and ODV in the literature.
Figure 3Western blot analysis of ubiquitylated proteins associated with the polyhedra matrix of BmNPV. Polyhedra matrix proteins were separated on SDS-PAGE gel and then analyzed using mouse monoclonal anti-ubiquitin antibody clone FK2 (A) and FK1 (B), rabbit monoclonal anti-ubiquitin antibody Lys48-specific clone Apu2 (C) and Lys63-specific clone Apu3 (D), and mouse monoclonal anti-linear poly-ubiquitin antibody clone LUB9 (E). Images were visualized using a secondary antibody conjugated to HRP and a chemiluminescence detection system.
Ubiquitylated proteins and their identified ubiquitylation site(s).
| Protein | Protein designation | Ubiquitylation site(s) |
|---|---|---|
| BmNPV ORF85 | BV/ODV-C42 | 225YAK(GG)IVLLQNVASQR238 |
| BmNPV ORF53 | DNAPOL | 463NDLSIISGQFNADKATAGISNLK485(GG) |
| BmNPV ORF15 | PKIP | 150LK(GG)LIAIK156 |
| BmNPV ORF26 | Ubiquitin | 43LIFAGK(GG)QLEDSK54, 55TMADYNIQK(GG)ESTLHMVLR72 |
| BGIBMGA001549-PA† | Ubiquitin |
1MQIFVK(GG)TLTGK11, 7TLTGK(GG)TITLEVE |
†The host gene BGIBMGA001549-TA encodes a pre-protein containing tandem head-to-tail repeats of the monomeric ubiquitin sequence. This pre-protein is then processed by de-ubiquitinating enzymes to produce two host ubiquitin monomers. The difference in the sequences of the two monomers is that one contains an alanine at amino acid position 19 (Ala19), and the other contains Pro19 at the same position. The Ala19 and Pro19 were underlined.
Figure 4Certain proteins associated with ODV were detected in the polyhedra matrix. The polyhedra matrix (lane P) and ODV (lane V) fractions were loaded for the Western blot analyses. The antibodies used for the blotting were described previously[17] and indicated to the right of each blot diagram. Lane M, the protein marker.
Figure 5Western blot analysis of the protein polyhedrin in the polyhedra matrix. Total proteins of the polyhedra matrix fraction were subjected to SDS-PAGE and then Western blot using a mouse monoclonal anti-polyhedrin antibody[166]. Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and a chemiluminescence detection system. Lane M, the protein marker.
Figure 6BM134 as a carrier to incorporate eGFP into the polyhedra matrix. (A) PCR identification of the ORF134 knockout bacmid. Lane M, DNA marker. Lane 1, DNA template of wildtype BmNPV bacmid and lane 2, template of the ORF134-disrupted bacmid, vBM134KO. (B) Construction of the BM134-eGFP-encoded nucleotide sequence- and polyhedrin-inserted bacmids vBM134Re-eGFP and vBM134KO-Polh. (C) Fluorescence of the polyhedra purified from BmN cells co-infected with viral stocks of vBM134Re-eGFP and vBM134KO-Polh. (D) Western blot analysis of purified polyhedra immobilized with the fusion protein BM134-eGFP using a mouse monoclonal anti-eGFP antibody. Lane M, pre-stained protein marker.